eg technology Ltd news.google.com
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
Posts from the MedTech world, all in one place. Feed curated by eg technology - a MedTech-focused Product Design, Engineering & Development Specialist
Feed on BlueskyFeeds Stats
- 💙 Liked by 1 user
- 📅 Updated 9 months ago
- ⚙️ Provider skyfeed.me
MedTech Likes over time
Like count prediction
The feed MedTech has not gained any likes in the last month.
Feed Preview for MedTech
NeuroOne Medical Technologies to host virtual investor webinar on Oct 7, 2025, showcasing innovative neurological medical technologies and recent corporate developments #MedTech #Neurology
0
0
0
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
news.google.com
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
0
0
0
Feed: "MedTech Dive - Latest News"
By: Nick Paul Taylor on Monday, September 29, 2025
www.medtechdive.com
EssilorLuxottica wins FDA OK for myopia-slowing eyeglass lenses
Investigators saw a 71% reduction in myopia progression in children who used the lenses for two years.
0
0
0
Feed: "MedTech Dive - Latest News"
By: Elise Reuter on Monday, September 29, 2025
www.medtechdive.com
Medtech firms splitting into ‘haves’ and ‘have-nots’: EY
The number of medtech funding rounds has declined in recent months, but the value of overall deals has increased, according to a new report from EY.
0
0
0
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
news.google.com
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
0
0
0
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
news.google.com
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
0
0
0
CorWave has reported encouraging results for its Left Ventricular Assisting System (LVAS), designed to restore natural pulsatility in advanced heart failure patients. Findings suggest the device can be implanted safely & may address key complications seen with current continuous-flow LVADs. #Medtech
www.massdevice.com
CorWave reports first patient results with membrane-based LVAS
CorWave presented positive interim results from its first-in-human study of the CorWave Left Ventricular Assisting System (LVAS).
0
0
1
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
news.google.com
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
0
0
0
We’re excited to share key findings from our network survey that explored the reimbursement landscape for innovative #medtech. Discover valuable insights on strategy development, engaging key partners, and navigating a complex system.
🔗 Read more: bit.ly/4gPIVFd
0
0
0
@tmdmag.bsky.social
about 7 hours agoPromex Industries expands with advanced laser and inspection systems. Learn how new capabilities support higher-density assemblies, flex substrates, and emerging chiplet architectures for precision and scale: buff.ly/MydwbDN #tmdmag #medtech #manufacturing #promexindustries #lasers
0
0
0
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
news.google.com
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
0
0
0
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
news.google.com
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
0
0
0
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
news.google.com
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
0
0
0
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
news.google.com
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
0
0
0
RDS lève 14 M€ — La medtech strasbourgeois RDS a annoncé le 29 septembre dans un communiqué la clôture d’une série A de 14 M€. Mené par le fonds SPI (Sociétés de Projets Industriels), géré pour le compte de l’État par Bpifrance, ce tour marque www.mind.eu.com/health/fi…
www.mind.eu.com
RDS lève 14 M€
La medtech strasbourgeois RDS a annoncé le 29 septembre dans un communiqué la clôture d’une série A de 14 M€. Mené par le fonds SPI (Sociétés de Projets Industriels), géré pour le compte de l’État par Bpifrance, ce tour marque
0
0
0
Glaukos is expanding its U.S. footprint with a major new facility in Alabama. The project marks a long-term investment in American #medtech manufacturing as the Trump administration questions the national security risk of medical device imports. www.medicaldesignandoutso….
www.medicaldesignandoutsourcing.com
Glaukos breaks ground on $80M facility in Alabama
Glaukos has begun construction on a new research, development, and manufacturing facility in Huntsville, Alabama.
0
0
0
🚨 Global Vascular Access Device Market – Growth Outlook to 2030, Projected to expand at a CAGR of ~6% by 2030 🚨
👉 Request Sample PDF: meditechinsights.com/vasc….
#Healthcare #MedicalDevices #MedTech
0
0
0
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
news.google.com
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
0
0
0
EY Report Reveals Resilience of MedTech Industry Amid Economic Challenges and Growth Opportunities #USA #New_York #MedTech #EY #Health
third-news.com
EY Report Reveals Resilience of MedTech Industry Amid Economic Challenges and Growth Opportunities
The latest EY Pulse of the MedTech Industry Report reveals sustained growth and expanding markets despite global uncertainties, emphasizing innovation and strategic opportunities.
0
0
0
Resonetics Expands Manufacturing Solutions through Eden Holdings Acquisition #United_States #MedTech #Nashua #Resonetics #Eden_Holdings
third-news.com
Resonetics Expands Manufacturing Solutions through Eden Holdings Acquisition
Resonetics enhances its MedTech portfolio by acquiring Eden Holdings, adding injection molding and machining capabilities for critical medical devices.
0
0
0
@healthdivine.bsky.social
about 12 hours ago🚑🛏️ Ambulance Stretchers evolving for speed, safety & patient comfort. Emergency care on wheels 🚨 #EmergencyCare #MedTech #HealthcareAccess
www.marketresearchfuture.….
www.marketresearchfuture.com
Ambulance Stretchers Market Size, Industry Growth Report 2035 | MRFR
Ambulance Stretchers Market 2025, Industry to reach 4.5 USD billion, at a 3.01% CAGR by growing size, share, top company analysis, segments research, trends and forecast report 2035
0
0
1
@healthdivine.bsky.social
about 12 hours ago🔍🧑⚕️ Ureteroscopes: advancing kidney stone & urinary care with precision-guided tech 💡 safer, smarter outcomes 🚑 #Urology #MedTech #PatientCare
www.marketresearchfuture.….
www.marketresearchfuture.com
Ureteroscope Market Size, Trends, Growth Outlook 2035
Ureteroscope Market growth is projected to reach 2.5 USD billion, at a 4.17% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast report 2025 to 2035
0
0
1
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
news.google.com
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
Ileadbms patents new SOS1/GTPase KRAS interaction inhibitors - BioWorld MedTech
0
0
0
From Overload to Insight: Why #AI Is Becoming an Essential Partner in #Oncology
www.onclive.com/view/from….
#MedSky #AImedicine #AI #HealthAI #AIinHealthcare #MedTech
www.onclive.com
From Overload to Insight: Why AI Is Becoming an Essential Partner in Oncology | OncLive
Brian P. Mulherin, MD, discusses how artificial intelligence is helping shape smarter cancer care.
0
0
0